Navigating FDA’s Guidance on AI and Non-Animal Models
The FDA and NIH aim to phase out animal testing for certain therapies, encouraging the adoption of AI technologies and organoids as non-animal alternatives.
Read MoreThe FDA and NIH aim to phase out animal testing for certain therapies, encouraging the adoption of AI technologies and organoids as non-animal alternatives.
Read MoreThe FDA and NIH announce an initiative to phase out animal testing for certain therapies, promoting AI and human organoid models to enhance safety assessments.
Read More6AM City has acquired AI newsletter startup Good Daily, expanding its subscriber base and utilizing AI technologies to streamline content creation processes.
Read More